Researchers at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center (NCCC) have found that a certain subpopulation of cells that enters a patient’s skin and blood during immunotherapy is behind the excellent and long-lasting immune responses to cancer that some survivors develop.
Press Release
Madhumala Sadanandappa Appointed to Early Career Leadership Program
The Genetics Society of America helps early career researchers develop leadership skills and build relationships within an international community of scientists.
Barbara Jobst MD, Dr. med, Named Chair of Neurology Department
Dartmouth-Hitchcock (D-H) and the Geisel School of Medicine at Dartmouth have appointed Barbara C. Jobst, MD, Dr. med, as the new chair of the Department of Neurology for D-H and Geisel.
Dartmouth Researchers Pilot FLASH Radiotherapy Beam Development for Treatment of Cancer
Dartmouth researchers convert a standard linear accelerator used for delivery of radiation therapy cancer treatment, to deliver an ultra-high-dose rate radiation therapy beam to patients “in a flash.”
Groundwork for COVID-19 Vaccine Laid at Dartmouth (Updated)
Discoveries originating in a basic science lab at the Geisel School of Medicine are being used in the newly approved COVID-19 vaccine from the Pfizer/BioNTech partnership.
Lionel D. Lewis, MD, Elected as a 2020 Fellow of the British Pharmacological Society
Lionel D. Lewis, MD, MA, MB BCh, has been elected as a fellow of the British Pharmacological Society, a premier global society in the science of pharmacology.
Dartmouth-led Research Featured in National Journal Focused on Health System Performance
New findings published by Dartmouth researchers and featured in a special issue of Health Services Research, are helping to generate new insights and knowledge about the prevalence, roles, and impact of integrated health systems.
Dartmouth Receives $2.4 Million to Aid Healthcare Providers’ COVID-19 Response
Researchers at Dartmouth’s Geisel School of Medicine have been awarded $2.4 million in federal funding to support ongoing studies aimed at enhancing American healthcare providers’ response to the COVID-19 pandemic.
International Study Shows that Active Surveillance Holds Promise as a Treatment Option for Low-Risk Thyroid Cancer
Results from a new study co-led by researchers at Dartmouth’s Geisel School of Medicine and the Department of Surgery at Kuma Hospital in Kobe, Japan, show that active surveillance can be successfully implemented as a viable treatment option for patients with low-risk thyroid cancer.
Dartmouth-Hitchcock and Geisel School of Medicine Name Steven L. Bernstein, MD, as Chief Research Officer and Associate Dean of Clinical Research
Steven L. Bernstein, MD, has been named as the inaugural Chief Research Officer for Dartmouth-Hitchcock (D-H), Associate Dean of Clinical Research at the Geisel School of Medicine at Dartmouth, and Director of the C. Everett Koop Institute at Geisel.









